A few weeks ago, I described what happens inside the brain when cannabis is used every day. Daily use does not simply produce a series of separate episodes of intoxication. Over time, it can shift the ...
In the US, about a quarter of a million people die each year from alcohol and drug-related illness, despite proven medical ...
Driven by social media hype and a growing distrust of public health guidance, consumer demand for experimental peptides has ...
Upfront PSMA PET imaging detects hidden metastases in early prostate cancer, altering treatment plans in up to one-third of ...
Dutch data highlight the importance of considering sex-specific differences in methotrexate drug survival when prescribing it ...
Announced positive topline induction data for SPY001 and SPY002 from Part A of the Phase 2 SKYLINE trial (“SKYLINE”), demonstrating best-in-class ...
Paul Hughes believes fighters are cheating the Professional Fighters League’s current drug testing program. Hughes recently ...
Oruka Therapeutics is rated a Sell, and its current valuation far exceeds risk-adjusted fundamentals. Read more on ORKA stock ...
MoonLake has consistently guided for a “mid-2026” primary endpoint readout from IZAR-1, its late-stage trial for sonelokimab in certain patients with active psoriatic arthritis.
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population; PSMAddition ...
The advertisement is a satire of pharmaceutical ads and includes a jingle accusing Sen. Blackburn of being in Big Pharma’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results